Related Experiment Videos
Triple valve replacement with Carpentier-Edwards bioprostheses
Soma Guhathakurta1, Kotturathu M Cherian
1Unit of Frontier Life Line, International Centre for Cardiothoracic and Vascular Diseases, Chennai, India.
Asian Cardiovascular & Thoracic Annals
|December 9, 2004
Summary
This case study highlights a young woman who underwent successful triple heart valve replacement using porcine bioprostheses. She remained asymptomatic for 15 years, demonstrating long-term durability and good function of the valves.
Area of Science:
- Cardiology
- Cardiac Surgery
- Bioprosthetic Valves
Background:
- Triple valve replacement is a complex cardiac surgery.
- Porcine bioprostheses are commonly used prosthetic heart valves.
- Long-term outcomes of triple valve replacement, especially in young patients, require further investigation.
Observation:
- A young woman underwent triple valve replacement with porcine bioprostheses.
- She maintained an asymptomatic status for 15 years post-surgery.
- Despite atrial fibrillation, she was anticoagulated with aspirin alone.
- She delivered a healthy child 2 years after the procedure.
Findings:
- The bioprostheses demonstrated excellent long-term function for 15 years.
- Echocardiographic findings remained stable from post-childbirth to the 15-year follow-up.
- Tricuspid annular calcification was noted, causing mild to moderate regurgitation.
Implications:
- This case suggests favorable long-term durability of porcine bioprostheses in young patients undergoing triple valve replacement.
- Aspirin may be a viable anticoagulation option in select patients with bioprosthetic valves, even during pregnancy.
- The findings support the potential for good quality of life and reproductive health after complex valve surgery.